Clinical Trials in Portland

Showing 6561-6580 of 10,048 trials

Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia

NCT03842605

This is a research study of adults with hemophilia that have limitations in elbow joint motion that is the result of bleeding into the joint. People with hemophilia who have bleeding into their elbow joint may have limitations in elbow joint movement and pain in the joint. This research is being done to determine the effect a strength training program has on the amount of movement people with hemophilia and elbow joint disease have.

HemophiliaElbow Joint Contracture

Oregon Health and Science University10 participantsStarted Oct 2012

Portland, Oregon, United States

COMPLETEDPhase 2< 1 mile

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

NCT00061893

RATIONALE: Drugs used in chemotherapy, such as vinblastine, work in different ways to stop tumor cells from dividing so they stop growing or die. Celecoxib may stop the growth of Ewing's sarcoma by stopping blood flow to the tumor. Combining more than one chemotherapy drug with celecoxib may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining low-dose vinblastine and celecoxib with standard regimens of combination chemotherapy in treating patients who have newly-diagnosed metastatic Ewing's sarcoma family of tumors.

Sarcoma

Children's Oncology Group38 participantsStarted Apr 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +98 more locations

Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Find Trials by Condition in Portland

A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

OGX-427 in Castration Resistant Prostate Cancer Patients

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

ESCAPE Migraine Trial

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements